(Reuters) -Deere & Co cut the lower end of its annual profit forecast and reported a fall in second-quarter results on Thursday due to economic uncertainty and softer demand for its tractors from farmers opting to rent machines instead. Farmers facing high interest rates …
XI’AN, China, May 15, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, announced today that it will effect a 1-for-25 reverse stock split …
Record-high backlog Record-high Nuclear quarterly revenue and Segment Adjusted EBIT MONTREAL, May 15, 2025 /CNW/ - AtkinsRéalis Group Inc. (TSX: ATRL), a world-class engineering services and nuclear company with offices around the world, today announced its financial results for the first quarter ended March …
Easy-to-Use Tech Preserves Photos, Documents and Awards to Pay Tribute to Veterans and Share Memories LOS ALAMITOS, Calif., May 15, 2025 /PRNewswire/ -- As loved ones prepare to gather this Memorial Day to honor those who have served the nation, they often seek meaningful …
Key Points Energy Transfer is an infrastructure company whose growth ambitions fit the current administration's plans. Clean energy specialist Clearway Energy has flourished in 2025, and offers a forward dividend yield of 6.1%. Starbucks has lost over a quarter of its value in just …
Fate Therapeutics (NASDAQ:FATE) First Quarter 2025 Results Key Financial Results Revenue: US$1.63m (down 15% from 1Q 2024). Net loss: US$37.6m (loss narrowed by 22% from 1Q 2024). US$0.32 loss per share (improved from US$0.47 loss in 1Q 2024). We've discovered 3 warning signs about …
CAE (TSE:CAE) Full Year 2025 Results Key Financial Results Revenue: CA$4.71b (up 9.9% from FY 2024). Net income: CA$405.3m (up from CA$325.3m loss in FY 2024). Profit margin: 8.6% (up from net loss in FY 2024). The move to profitability was primarily driven by …
BOSTON, May 15, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (“Aura”) (Nasdaq: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced the launch of an underwritten public offering of shares of its common stock and …
By David Bautz, PhDNASDAQ:ARWRREAD THE FULL ARWR RESEARCH REPORT Business Update Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) has a robust pipeline of RNA interference (RNAi) therapies utilizing the company’s TRiM™ platform. The TRiM platform allows for targeting of RNAi therapeutics to seven different cell types, including …
We didn't see Chartwell Retirement Residences' (TSE:CSH.UN) stock surge when it reported robust earnings recently. We think that investors might be worried about the foundations the earnings are built on. We've found 21 US stocks that are forecast to pay a dividend yield of …